133 related articles for article (PubMed ID: 18200520)
1. Antiangiogenic drugs: current knowledge and new approaches to cancer therapy.
Mauriz JL; González-Gallego J
J Pharm Sci; 2008 Oct; 97(10):4129-54. PubMed ID: 18200520
[TBL] [Abstract][Full Text] [Related]
2. Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine.
Alsaab HO; Al-Hibs AS; Alzhrani R; Alrabighi KK; Alqathama A; Alwithenani A; Almalki AH; Althobaiti YS
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562829
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.
El-Kenawi AE; El-Remessy AB
Br J Pharmacol; 2013 Oct; 170(4):712-29. PubMed ID: 23962094
[TBL] [Abstract][Full Text] [Related]
4. Changing landscape of anti-angiogenic therapy: Novel approaches and clinical perspectives.
Gacche RN
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189020. PubMed ID: 37951481
[TBL] [Abstract][Full Text] [Related]
5. Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer.
Mukherjee A; Madamsetty VS; Paul MK; Mukherjee S
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936832
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment.
Schneider BP; Shen F; Miller KD
Lancet Oncol; 2012 Oct; 13(10):e427-36. PubMed ID: 23026828
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response.
Zheng Y; Pan YQ; Liao K; Yu K; Wu Q; Chen Y; Deng Y; Sun H; Pu H; Ju HQ; Xu RH; Liu ZX
Clin Transl Med; 2023 Dec; 13(12):e1501. PubMed ID: 38037528
[No Abstract] [Full Text] [Related]
8. Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment.
Teleanu RI; Chircov C; Grumezescu AM; Teleanu DM
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31905724
[TBL] [Abstract][Full Text] [Related]
9. Tumour Angiogenesis and Angiogenic Inhibitors: A Review.
Yadav L; Puri N; Rastogi V; Satpute P; Sharma V
J Clin Diagn Res; 2015 Jun; 9(6):XE01-XE05. PubMed ID: 26266204
[TBL] [Abstract][Full Text] [Related]
10. Decoding Tumor Angiogenesis for Therapeutic Advancements: Mechanistic Insights.
Kaur G; Roy B
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672182
[TBL] [Abstract][Full Text] [Related]
11. Novel Products as Promising Therapeutic Agents for Angiogenesis Inhibition.
Sultana S; Sultana S; Mir Najib Ullah SN; Zafar A
Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38204254
[TBL] [Abstract][Full Text] [Related]
12. Potential of natural flavonoids to target breast cancer angiogenesis (review).
Wang Y; Huang M; Zhou X; Li H; Ma X; Sun C
Br J Pharmacol; 2023 Nov; ():. PubMed ID: 37940117
[TBL] [Abstract][Full Text] [Related]
13. The past and future of angiogenesis as target for cancer therapy and prevention.
Albini A; Noonan DM; Corradino P; Magnoni F; Corso G
Cancer Prev Res (Phila); 2024 May; ():. PubMed ID: 38714356
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic mechanisms and factors in breast cancer treatment.
Castañeda-Gill JM; Vishwanatha JK
J Carcinog; 2016; 15():1. PubMed ID: 27013929
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in diseases: A half-century excursion from the initial therapeutic concept to current clinical benefits.
Cao Y
Chin Med J (Engl); 2024 Mar; 137(6):636-637. PubMed ID: 38384186
[No Abstract] [Full Text] [Related]
16. Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer.
Wang Y; Chen T; Li K; Mu W; Liu Z; Shi A; Liu J; Zhao W; Lian S; Huang S; Pan C; Zhang Z
Front Oncol; 2021; 11():777617. PubMed ID: 34778094
[TBL] [Abstract][Full Text] [Related]
17. Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review.
Fernández-Palanca P; Méndez-Blanco C; Fondevila F; Tuñón MJ; Reiter RJ; Mauriz JL; González-Gallego J
Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33445767
[TBL] [Abstract][Full Text] [Related]
18. Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules.
Ho SY; Chen PR; Chen CH; Tsai NM; Lin YH; Lin CS; Chuang CH; Huang XF; Chan YL; Liu YK; Chung CH; Weng SL; Liao KW
J Nanobiotechnology; 2020 Apr; 18(1):58. PubMed ID: 32272948
[TBL] [Abstract][Full Text] [Related]
19. Interferon priming is essential for human CD34+ cell-derived plasmacytoid dendritic cell maturation and function.
Laustsen A; Bak RO; Krapp C; Kjær L; Egedahl JH; Petersen CC; Pillai S; Tang HQ; Uldbjerg N; Porteus M; Roan NR; Nyegaard M; Denton PW; Jakobsen MR
Nat Commun; 2018 Aug; 9(1):3525. PubMed ID: 30166549
[TBL] [Abstract][Full Text] [Related]
20. Targeted antivascular therapy with the apolipoprotein(a) kringle V, rhLK8, inhibits the growth and metastasis of human prostate cancer in an orthotopic nude mouse model.
Lee HJ; Yu HK; Papadopoulos JN; Kim SW; He J; Park YK; Yoon Y; Kim JS; Kim SJ
Neoplasia; 2012 Apr; 14(4):335-43. PubMed ID: 22577348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
